Literature DB >> 20025579

Cardiovascular remodeling induced by passive smoking.

Marcos F Minicucci1, Paula S Azevedo, Sergio A R Paiva, Leonardo A M Zornoff.   

Abstract

Coronary heart disease (CHD) is the most common cause of death in many developed countries. The major risk factors for CHD are smoking, high blood pressure, diabetes, high cholesterol levels, and lack of physical activity. Importantly, passive smoke also increases the risk for CHD. The mechanisms involved in the effects of passive smoke in CHD are complex and include endothelial dysfunction, lipoprotein modification, increased inflammation and platelet activation. Recently, several studies have shown that exposure to tobacco smoke can result in cardiac remodeling and compromised cardiac function. Potential mechanisms for these alterations are neurohumoral activation, oxidative stress, and MAPK activation. Although the vascular effects of cigarette smoke exposure are well known, the effects of tobacco smoking on the heart have received less attention. Therefore, this review will focus on the recent findings as to the effects of passive smoking in acute and chronic phases of vascular and cardiac remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025579     DOI: 10.2174/1871528110908050334

Source DB:  PubMed          Journal:  Inflamm Allergy Drug Targets        ISSN: 1871-5281


  8 in total

1.  Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice.

Authors:  M A Hassan Talukder; Wesley M Johnson; Saradhadevi Varadharaj; Jiarui Lian; Patrick N Kearns; Mohamed A El-Mahdy; Xiaoping Liu; Jay L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-05       Impact factor: 4.733

2.  Ultrafine Particle Exposure Reveals the Importance of FOXO1/Notch Activation Complex for Vascular Regeneration.

Authors:  Kyung In Baek; René R Sevag Packard; Jeffrey J Hsu; Arian Saffari; Zhao Ma; Anh Phuong Luu; Andrew Pietersen; Hilary Yen; Bin Ren; Yichen Ding; Constantinos Sioutas; Rongsong Li; Tzung K Hsiai
Journal:  Antioxid Redox Signal       Date:  2017-11-17       Impact factor: 8.401

3.  Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract.

Authors:  Jianli Niu; Kangkai Wang; Pappachan E Kolattukudy
Journal:  J Pharmacol Exp Ther       Date:  2011-04-04       Impact factor: 4.030

Review 4.  Advanced microscopy to elucidate cardiovascular injury and regeneration: 4D light-sheet imaging.

Authors:  Kyung In Baek; Yichen Ding; Chih-Chiang Chang; Megan Chang; René R Sevag Packard; Jeffrey J Hsu; Peng Fei; Tzung K Hsiai
Journal:  Prog Biophys Mol Biol       Date:  2018-05-09       Impact factor: 3.667

5.  Cardiac-specific overexpression of metallothionein rescues against cigarette smoking exposure-induced myocardial contractile and mitochondrial damage.

Authors:  Nan Hu; Xuefeng Han; Erin K Lane; Feng Gao; Yingmei Zhang; Jun Ren
Journal:  PLoS One       Date:  2013-02-19       Impact factor: 3.240

6.  Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells Attenuate Cigarette Smoke-Induced Cardiac Remodeling and Dysfunction.

Authors:  Yingmin Liang; Xiang Li; Yuelin Zhang; Sze Chun Yeung; Zhe Zhen; Mary S M Ip; Hung Fat Tse; Qizhou Lian; Judith C W Mak
Journal:  Front Pharmacol       Date:  2017-07-28       Impact factor: 5.810

7.  Association of particulate air pollution and secondhand smoke on endothelium-dependent brachial artery dilation in healthy children.

Authors:  Mohammad Hashemi; Mohammad Reza Afshani; Marjan Mansourian; Parinaz Poursafa; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2012-04       Impact factor: 1.852

8.  Real-Ambient Particulate Matter Exposure-Induced Cardiotoxicity in C57/B6 Mice.

Authors:  Lianhua Cui; Limei Shi; Daochuan Li; Xiaobo Li; Xuan Su; Liping Chen; Qixiao Jiang; Menghui Jiang; Jing Luo; Andong Ji; Chen Chen; Jianxun Wang; JingLong Tang; Jingbo Pi; Rui Chen; Wen Chen; Rong Zhang; Yuxin Zheng
Journal:  Front Pharmacol       Date:  2020-03-31       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.